A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment
with clevudine, at one of three doses, in patients chronically infected with hepatitis B
virus.